Posted: March 14th, 2013 | Author: Michael Courtenay | Filed under: Medicated | Tags: Acetylsalicylic Acid, American Cancer Society, Antiplatelet, Aspirin, Drugs, Esterification Reaction, medicine, Peter Mac, Salicylic Acid | No Comments »
An American study has found that women who take regular doses of aspirin may be less likely to develop melanoma. Researchers followed almost 60,000 women aged 50 to 79 for an average of 12 years.
Overall, women who took regular doses of aspirin had a 21 per cent lower risk of developing melanoma than non-users. The longer the women used aspirin, the lower the risk.
Alecia Brooks from the Cancer Institute of New South Wales says Australia has the highest melanoma rates in the world. She says while it is interesting research, covering up from the sun remains the best way to protect yourself.
“With the highest rates of melanoma in the world, we’re still obviously a little bit concerned that people may feel that if they take aspirin then they can be less vigilant about staying out in the sun,” she said.
The research is published in the journal Cancer.
Posted: November 9th, 2012 | Author: Verity Penfold | Filed under: Medicated | Tags: Aspirin, Autumn Crocus, Colchicine, Colchicum Autumnale, Familial Mediterranean Fever, Gout, Heart Attack Medication, Heart Attack Preventative, Meadow Saffron | No Comments »
A West Australian-led study has found a person’s risk of heart attack could be dramatically reduced by taking a common medication to treat gout. More than 500 people participated in the Heart Research Institute study at Perth’s Sir Charles Gairdner Hospital.
Some participants were given the Gout treatment/medication Colchicine. It’s a toxic natural product and secondary metabolite, originally extracted from plants of the genus Colchicum, Meadow Saffron, Autumn Crocus, Colchicum Autumnale.
Colchicine has been used originally to treat rheumatic complaints, especially gout, and still finds use for these purposes today despite dosing issues concerning its toxicity. It’s also prescribed for its cathartic and emetic effects.
In addition to gout, colchicine is use to treat familial Mediterranean fever, pericarditis, and Behçet’s disease. It is also being investigated for its use as an anticancer drug, it’s use as a heart attack preventative is a first.
Lead researcher Professor Peter Thompson says the results are very exciting. ”When we gave the drug to the patients compared with those who did not receive the drug, the risk of heart attack was reduced by half and the side effects were minimal,” Professor Thompson said. ”Larger and more detailed studies are yet required to check that there are no unusual or unexpected side effects, but at this stage, it’s looking highly promising.”
Professor Thompson says the results could change the way heart disease is treated around the world. ”This is a drug which is relatively inexpensive and widely available and has quite dramatic effects and other drugs are being trialled and developed but they are quite expensive and relatively inaccessible,” Professor Thompson has presented his findings at the American Heart Association conference in Los Angeles :: Read the full article »»»»
Posted: August 11th, 2012 | Author: Verity Penfold | Filed under: Cankler Science News, Favorite New Thought, Medicated | Tags: Acetylsalicylic Acid, American Cancer Society, Antiplatelet, Aspirin, Drugs, Esterification Reaction, medicine, Peter Mac, Salicylic Acid | No Comments »
It’s NO secret that aspirin is my favourite drug! - Australian Scientists Probe Aspirins Role in Cancer Treatment + www.cankler.com.au/wiki-aspirin - since it’s discovery by Arthur Eichengrün in the 1880s, this wonder of nature has been a cure-all. Aspirin has been in and out of vogue since the early 20th century, now thankfully, it’s back in.
Back in February we looked at new work by researchers from Melbourne’s Peter MacCallum Cancer Institute, who said that they had made an important discovery about how cancer spreads. A 2010 article published in the Journal of Clinical Oncology had previously suggested that aspirin may reduce the risk of death from breast cancer.
Scientists have known for years that common drugs like aspirin can help cancer patients, but they weren’t sure why. Peter Mac researchers have now found a link between drugs like aspirin and the ability for cancer tumours to spread in the body.
More anecdotael evidence of this wonder drugs fight against cancer has surfaced via a survey undertaken by Eric Jacobs at the American Cancer Society. The study of more than 100,000 healthy people found that those who took a dose of aspirin every day were much less likely to develop and die from a broad range of cancers :: Read the full article »»»»
Posted: February 14th, 2012 | Author: Verity Penfold | Filed under: Cankler Science News, Medicated | Tags: Aspirin, Cancer Research, Clinical Oncology, Non-steroidal Anti-inflammatories, NSAID, Peter MacCallum Cancer Institute | No Comments »
Researchers from Melbourne’s Peter MacCallum Cancer Institute – PMCI – say they have made an important discovery about how cancer spreads. A 2010 article published in the Journal of Clinical Oncology has previously suggested that aspirin may reduce the risk of death from breast cancer. While the information has been well-circulated by the media, official health bodies and medical groups have expressed concern over the touting of aspirin as a “miracle drug”
Scientists have known for years that common drugs like aspirin can help cancer patients, but they weren’t sure why. PMCI researchers have now found a link between drugs like aspirin and the ability for cancer tumours to spread in the body. Read the full article »»»»
Posted: January 11th, 2011 | Author: Verity Penfold | Filed under: Wiki | Tags: Acetylsalicylic Acid, Antiplatelet, Arthur Eichengrün, Aspirin, Drugs, Esterification Reaction, medicine, Salicylic Acid, Wiki | No Comments »
Aspirin, acetylsalicylic acid, is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatorymedication. Aspirin was first isolated by Felix Hoffmann, a chemist with the German drug company Bayer, under the direction of Arthur Eichengrün.
Salicylic acid, the main metabolite of aspirin, is an integral part of human and animal metabolism. While in humans much of it is attributable to diet, a substantial part is synthesized endogenously.
Aspirin also has an antiplatelet effect by inhibiting the production of thromboxane, which under normal circumstances binds platelet molecules together to create a patch over damaged walls of blood vessels. Because the platelet patch can become too large and also block blood flow, locally and downstream, aspirin is also used long-term, at low doses, to help prevent heart attacks, strokes, and blood clot formation.
It has been well established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue. Some people take a daily aspirin to reduce their risk of heart attack. New evidence suggests aspirin may be a powerful tool in cancer prevention, as well.
The main undesirable side effects of aspirin taken by mouth are gastrointestinal ulcers, stomach bleeding, and tinnitus, especially in higher doses. In children and adolescents, aspirin is no longer indicated to control flu-like symptoms or the symptoms of chickenpox or other viral illnesses, because of the risk of Reye’s syndrome :: Read the full article »»»»